Stuttgart - Delayed Quote EUR

CytomX Therapeutics Inc (6C1.SG)

Compare
0.8395 +0.0280 (+3.45%)
At close: November 22 at 9:31 PM GMT+1
Loading Chart for 6C1.SG
DELL
  • Previous Close 0.8115
  • Open 0.8070
  • Bid 0.8415 x --
  • Ask 0.8595 x --
  • Day's Range 0.8070 - 0.8400
  • 52 Week Range 0.7955 - 4.4380
  • Volume 2,500
  • Avg. Volume 359
  • Market Cap (intraday) --
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date Nov 7, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Recent News: 6C1.SG

View More

Performance Overview: 6C1.SG

Trailing total returns as of 11/22/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

6C1.SG
38.63%
S&P 500
25.15%

1-Year Return

6C1.SG
32.62%
S&P 500
31.54%

3-Year Return

6C1.SG
86.65%
S&P 500
27.06%

5-Year Return

6C1.SG
83.87%
S&P 500
92.34%

Compare To: 6C1.SG

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 6C1.SG

View More

Valuation Measures

Annual
As of 11/22/2024
  • Market Cap

    66.53M

  • Enterprise Value

    -35.67M

  • Trailing P/E

    5.49

  • Forward P/E

    13.81

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.58

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    --

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: 6C1.SG

View More

Company Insights: 6C1.SG

Research Reports: 6C1.SG

View More